Bluejay Diagnostics Ratios (2022-2023) | BJDX

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Profitability
Gross Margin 19.64%
EBT Margin -3,770.21%-797.35%-1,917.69%-3,200.75%
EBIT Margin -3,770.21%-797.35%-1,917.69%-3,200.75%
EBITDA Margin -3,770.21%-797.35%-1,917.69%-3,200.75%
Operating Margin -3,770.21%-797.35%-1,917.69%-3,200.75%
Net Margin -3,770.21%-797.35%-1,917.69%-3,200.75%
FCF Margin -3,506.51%-715.67%-2,343.30%-1,850.58%
Efficiency
Inventory Average 0.78M
Assets Average 19.07M16.89M14.61M12.20M9.68M8.36M
Equity Average 17.57M15.23M12.68M10.35M7.77M5.79M
Invested Capital 18.49M16.66M13.81M11.54M9.16M6.38M5.21M
Asset Utilization Ratio 0.020.030.020.03
Leverage & Solvency
Equity Ratio 0.920.920.880.850.840.750.63
Valuation
Enterprise Value -17.12M-15.34M-13.29M-10.11M-6.78M-5.10M-5.08M
Return Ratios
Return on Sales -37.70%-7.97%-30.66%-19.18%-32.01%-34.87%-24.23%
Return on Capital Employed -0.72%-0.92%-1.38%
Return on Assets -0.64%-0.81%-1.12%-0.96%
Return on Equity -0.74%-0.96%-1.40%-1.39%